Physician profile
Caroline F Sizer
NPI 1932492022
$21,459.77
in general payments reported to CMS, 2019-2025
6 companies · $12K in 2025
The $12K reported for 2025 was more than what 97% of Brain Injury Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $165).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.60 · 2022: $70.57 · 2023: $364 · 2024: $8,835 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $2,537 · Food and Beverage: $1,650 · Consulting Fee: $1,150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,031.25 |
| Travel and Lodging | $2,537.04 |
| Food and Beverage | $1,650.31 |
| Consulting Fee | $1,150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $20,763.30 | 2022-2025 | Botox |
| Merz Pharmaceuticals, LLC | $321.38 | 2023-2025 | Xeomin |
| Medtronic, INC. | $157.62 | 2023 | Synchromedii |
| Ipsen Biopharmaceuticals, INC | $136.00 | 2024-2025 | Dysport |
| Amneal Pharmaceuticals LLC | $60.87 | 2023 | Lioresal (Baclofen) |
| Allergan, INC. | $20.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Sizer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.